Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A blood lipid-lowering and anti-oxidation technology, applied in the field of plant materials, can solve the problems of expensive imported drugs, unbearable for ordinary patients, occasional myopathy and rhabdomyolysis, etc.
Inactive Publication Date: 2003-11-05
SHAANXI NORMAL UNIV
View PDF0 Cites 14 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0007] Among the above-mentioned drugs, statins and fibrates have better blood lipid-lowering effects, but they all have certain side effects. The main adverse reactions of statins are abnormal liver function and myopathy, and the most common adverse reactions of fibrates are gastrointestinal reactions. It can cause stones, so patients with gallstones or gallbladder disease are contraindicated. Although the combination of fibrates and statins is also very effective, but occasionally myopathy and rhabdomyolysis occur.
[0008] At present, there are no blood-lipid-lowering drugs on the market in my country, and the imported related drugs are expensive and unaffordable for ordinary patients. Therefore, the development of cheap blood-lipid-lowering drugs without side effects is an urgent problem to be solved
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0024] Taking the preparation of 1000 tablets of the product of the present invention as an example, the raw materials, auxiliary materials and their proportions are as follows:
[0025] Forsythin 30g
[0026] Starch 150g
[0027] Lactose 120g
[0028] The preparation process is carried out according to the conventional process of pharmacy tablets, each tablet weighs 0.3g and contains 30mg forsythin.
[0029] Usage and dosage: Orally, take one tablet each time, three times a day, reduce for children.
Embodiment 2
[0031] Taking the preparation of 1000 capsules of the product of the present invention as an example, the raw materials, auxiliary materials and their proportions are as follows:
[0032] Forsythin 30g
[0033] Corn starch 35g
[0034] Magnesium stearate 5g
[0035] The preparation process is carried out according to the conventional process of pharmacy capsules, and each capsule contains 30 mg of forsythin.
[0036] Usage and dosage: Orally, one capsule each time, three times a day, reduce for children.
Embodiment 3
[0038] Taking the preparation of 1000g of the product granules of the present invention as an example, the raw materials and auxiliary materials and their proportions are as follows:
[0039] Forsythin 10g
[0040] Cane sugar powder 650g
[0041] Dextrin 340g
[0042] The preparation process is carried out according to the conventional process of pharmaceutics granules, and 1 g contains 10 mg of forsythin.
[0043] Usage and dosage: Orally, 3g each time, three times a day, reduce for children.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The orally taken antioxidant and antilipemic medicines include solid orally taken preparation prepared with forsythin and solid excipient in the weight ratio of 0.01-4 through mixing and conventionaltechnological process, and liquid orally taken preparation prepared with forsythin and liquid excipient in the weight ratio of 0.003-0.01 through mixing and conventional technological process. Test shows that forsythin as the active component of the present invention has excellent effect of clearing away hydroxy radical and can inhibit the oxidizing damage in tissue and cell organ level. The medicine of the present invention has also functions of delaying senility and reducing blood fat, etc.
Description
Technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Oxygen free radicals play a very important role in the occurrence and development of many human diseases, such as aging, tumor occurrence, cardiovascular and cerebrovascular diseases, organ ischemia-reperfusion injury, senile dementia, Parkinson’s disease, Arteriosclerosis, cataracts, complications of diabetes, alcoholic liver injury, chronic hepatitis, emphysema, etc. With the deepening of theoretical research on the relationship between oxygen free radicals and diseases, the application value of antioxidants has been paid more and more attention, and relevant antioxidant drugs have also received increasing attention. Some antioxidants are even used as ingredients in health foods, such as Vitamin E family, carotene, unsaturat...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more